Back to Search
Start Over
Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol
Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol
- Source :
- Lancet (London, England). 349(9064)
- Publication Year :
- 1997
-
Abstract
- Summary Background Multidrug-resistant tuberculosis (MDR-TB) is associated with substantial morbidity, despite drug therapy. Interferon-γ, a cytokine produced mainly by CD4 T lymphocytes, can activate alveolar macrophages, important effector cells in host immunity against Mycobacterium tuberculosis . We investigated safety and tolerability of aerosolised interferon-γ in patients with MDR-TB, and assessed its efficacy in terms of sputum-smear grades. Methods We did an open-label trial of aerosol interferon-γ given to five patients with smears and cultures positive for pulmonary MDR-TB, despite documented adherence to therapy. The patients received aerosol interferon-γ 500 μg three times a week for 1 month. Safety and tolerability were assessed, and, as well as routine clinical assessments, sputum samples for smear and culture were collected at entry and weekly. Computed tomography scans of the chest were done at baseline and after therapy ended. Findings Interferon-γ was well tolerated by all patients. In all five, bodyweight stabilised or increased. Sputum acid-fast-bacillus smears became negative in all patients, and the time to positive culture increased (from 17 to 24 days, not significant), which suggested that the mycobacterial burden had decreased. The size of cavitary lesions was reduced in all patients, 2 months after treatment had ended. Interpretation Preliminary data suggest that aerosol interferon-γ is a well-tolerated treatment that may be useful as adjunctive therapy in patients with MDR-TB who are otherwise not responding well to therapy.
- Subjects :
- CD4-Positive T-Lymphocytes
Male
medicine.medical_specialty
Tuberculosis
Antitubercular Agents
Gastroenterology
Drug Administration Schedule
Mycobacterium tuberculosis
Interferon-gamma
Pharmacotherapy
Internal medicine
Administration, Inhalation
Macrophages, Alveolar
Tuberculosis, Multidrug-Resistant
medicine
Humans
Interferon gamma
Tuberculosis, Pulmonary
Aerosols
Lung
biology
business.industry
Respiratory disease
Body Weight
Sputum
General Medicine
biology.organism_classification
medicine.disease
Recombinant Proteins
medicine.anatomical_structure
Tolerability
Immunology
Female
medicine.symptom
Safety
business
Tomography, X-Ray Computed
medicine.drug
Follow-Up Studies
Subjects
Details
- ISSN :
- 01406736
- Volume :
- 349
- Issue :
- 9064
- Database :
- OpenAIRE
- Journal :
- Lancet (London, England)
- Accession number :
- edsair.doi.dedup.....c2b9af540d81dab0c3bb1843d110ec5e